Many have the same questions as 2026 approaches
In one study, for example, dysesthesia appeared in nearly 21 percent of retatrutide users versus less than 1 percent on placebo
Carnitine dynamics and their effects on hyperammonemia in cirrhotic Japanese patients
Whilst natural approaches to enhancing GLP-1 provide valuable metabolic benefits , certain clinical situations warrant consideration of pharmaceutical GLP-1 receptor agonists
Given that chronic hepatitis and cirrhosis are major risk factors for HCC, the anti-inflammatory and anti-fibrotic effects of L-carnitine could theoretically contribute to reduced HCC risk in patients with advanced MASLD, but this hypothesis awaits clinical validation
The gut microbiota, a critical interface mediating host-environment interactions, is essential for maintaining intestinal homeostasis